Inventor
FLAMME INGO
DE24 patents
⚠️ This page may combine multiple inventors who share the name “FLAMME INGO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BAYER IP GMBH
5 patentsUS9168249B2Oct 27, 2015
Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
BAYER IP GMBH1 citations61
US8987261B2Mar 24, 2015
Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
BAYER IP GMBH1 citations61
US9315543B2Apr 19, 2016
Tyrosine based linkers for the releasable connection of peptides
BAYER IP GMBH1 citations51
US9649363B2May 16, 2017
Polyethylene glycol based prodrug of adrenomedullin and use thereof
BAYER IP GMBH0 citations50
US9603936B2Mar 28, 2017
Polyethylene glycol based prodrug of adrenomedullin and use thereof
BAYER IP GMBH0 citations50
THEDE KAI
4 patentsUS8653111B2Feb 18, 2014
Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
THEDE KAI7 citations83
US8389520B2Mar 5, 2013
Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
THEDE KAI8 citations83
US8524699B2Sep 3, 2013
Substituted dihydropyrazolones and use thereof as HIF-prolyl-4-hydroxylase inhibitors
THEDE KAI6 citations72
US8609698B2Dec 17, 2013
Substituted dipyridyl-dihydropyrazolones and use thereof
THEDE KAI4 citations61
BAYER AG
4 patentsUS12503491B2Dec 23, 2025
MASP inhibitory compounds and uses thereof
BAYER AG0 citations56
US12384843B2Aug 12, 2025
Anti-semaphorin 3A antibodies
BAYER AG0 citations56
US12173068B2Dec 24, 2024
Anti-sema3a antibodies and uses thereof
BAYER AG0 citations56
US11667675B2Jun 6, 2023
MASP inhibitory compounds and uses thereof
BAYER AG0 citations56
JESKE MARIO
2 patentsFLAMME INGO
2 patentsUS8252817B2Aug 28, 2012
Dipyridyl-dihydropyrazolones and their use
FLAMME INGO7 citations81
US9085572B2Jul 21, 2015
4-(pyridin-3-yl)-2(pyridin-2yl)-1,2-dihydro-3H-pyrazol-3-one derivatives as specific HIF-pyrolyl-4-hydroxylase inhibitors for treating cardiovascular and haematological diseases
FLAMME INGO1 citations46